Comment to: ‘Evidence and consensus based (S3) Guidelines for the Treatment of Actinic Keratosis’

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 11, 2016, Pages e114-

  Pellacani, G ^a   Neri, L ^b   Longo, C ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; CARCINOGENESIS; FIELD CANCERIZATION; HUMAN; INVASIVE SQUAMOUS CELL CARCINOMA; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; CONSENSUS; KERATOSIS; SKIN TUMOR;

CONSENSUS; HUMANS; KERATOSIS; KERATOSIS, ACTINIC; SKIN NEOPLASMS;

EID: 84945572480     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13355     Document Type: Letter

References (9)

1. Werner RN, Stockfleth E, Connoly SM et al. Evidence and consensus based (S3) Guidelines for the Treatment of Actinic Keratosis. JEADV 2015; doi: 10.1111/jdv.13179. [E-pub ahead of print]
2. Vatve M, Ortonne JP, Birch-Machin MA, Gupta G. Management of field change in actinic keratosis. Br J Dermatol 2007; 157 (Suppl 2): 21–24.
3. Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol 2013; 169: 502–518.
4. Torezan LA, Festa-Neto C. Cutaneous field cancerization: clinical, histopathological and therapeutic aspects. An Bras Dermatol 2013; 88: 775–786.
5. Malvehy J. A new vision of actinic keratosis beyond visible clinical lesions. J Eur Acad Dermatol Venereol 2015; 29 (Suppl 1): 3–8.
6. Vanharanta S, Massagué J. Field cancerization: something new under the sun. Cell 2012; 149: 1179–1181.
7. Del Rosso JQ, Kircik L, Goldenberg G, Brian B. Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach. J Clin Aesthet Dermatol 2014; 7 (Suppl S2–S12): S2–S12.
8. Krawtchenko N, Roewert-Huber J, Ulrich M, Mann I, Sterry W, Stockfleth E. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol 2007; 157 (Suppl 2): 34–40.
9. Hofbauer G, Anliker M, Boehncke WH et al. Swiss clinical practice guidelines on field cancerization of the skin. Swiss Med Wkly 2014; 144: w14026 doi: 10.4414/smw.2014.14026. eCollection 2014.